David Altarac, Chief Medical Officer at Entasis Therapeutics Holdings Inc. (ETTX), sold 3,759 shares at $3.19 ($12K) on 2021-10-19, disclosed to the SEC on 2021-10-20.
Open-market sale of $12k ETTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.